Annual report pursuant to Section 13 and 15(d)

Statements of Cash Flows

v2.4.1.9
Statements of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:    
Net loss $ (5,789,519)us-gaap_NetIncomeLoss $ (16,068,754)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash used in operating activities:    
Technology access fee paid in common stock and convertible note payable to shareholder   6,000,000ogen_TechnologyAccessFeePaidInCommonStockAndConvertibleNotePayableToShareholder
Depreciation and amortization 27,667us-gaap_DepreciationAndAmortization 76,487us-gaap_DepreciationAndAmortization
Loss on sale of property and equipment 203us-gaap_GainLossOnSaleOfPropertyPlantEquipment  
Stock issued as compensation to non-employee directors 102,500us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims  
Stock-based compensation expense 184,532us-gaap_StockOptionPlanExpense 3,449,650us-gaap_StockOptionPlanExpense
Changes in operating assets and liabilities:    
Accounts receivable, net 48,826us-gaap_IncreaseDecreaseInAccountsReceivable 5,361us-gaap_IncreaseDecreaseInAccountsReceivable
Inventory, net (150,806)us-gaap_IncreaseDecreaseInInventories (164,205)us-gaap_IncreaseDecreaseInInventories
Prepaid expenses and other current assets 214,831us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets 203,601us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Accounts payable and accrued expenses (199,747)us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities (234,523)us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
Deferred revenue 2,383us-gaap_IncreaseDecreaseInDeferredRevenue (32,150)us-gaap_IncreaseDecreaseInDeferredRevenue
Net cash used in operating activities (5,559,130)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (6,764,533)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities:    
Proceeds from sale of property and equipment 424us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment  
Purchase of property and equipment (110,673)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (18,809)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Net cash used in investing activities (110,249)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (18,809)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash flows from financing activities:    
Exercise of common stock options   39,800us-gaap_ProceedsFromStockOptionsExercised
Payments on short-term notes payable (158,210)us-gaap_RepaymentsOfShortTermDebt (140,931)us-gaap_RepaymentsOfShortTermDebt
Payment of income taxes associated with stock based compensation   (631,743)us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation
Net proceeds from issuance of common stock   13,804,996us-gaap_ProceedsFromIssuanceOfCommonStock
Restricted cash released   61,763us-gaap_ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
Net cash (used in) or provided by financing activities (158,210)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 13,133,885us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Net (decrease) increase in cash and cash equivalents (5,827,589)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 6,350,543us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents at beginning of period 16,276,510us-gaap_CashAndCashEquivalentsAtCarryingValue 9,925,967us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents at end of period 10,448,921us-gaap_CashAndCashEquivalentsAtCarryingValue 16,276,510us-gaap_CashAndCashEquivalentsAtCarryingValue
Supplemental disclosure of cash flow information:    
Interest paid 4,058us-gaap_InterestPaid 3,108us-gaap_InterestPaid
Non-cash investing and financing activities:    
Conversion of convertible note payable and accrued interest to common shares   1,969,040us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
Borrowings under short term notes payable for prepaid expense 158,999us-gaap_LiabilitiesAssumed1 157,005us-gaap_LiabilitiesAssumed1
Par value of common stock issued for cashless exercise of warrants $ 135ogen_CommonStockIssuedDuringPeriodParValueForWarrantsExercise $ 106ogen_CommonStockIssuedDuringPeriodParValueForWarrantsExercise